Fennec Pharmaceuticals Inc.

(FRX:CA)

By |

Profile

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.

Contact Information

Website: www.fennecpharma.com
Email: info@fennecpharma.com
Main Phone: +1 919 636-4530
Address: 68 TW Alexander Drive
Address 2: P.O Box 13628
State: NC
City / Town: Research Triangle Park
Country: USA
Postal Code: 27709

Issuer Information

Exchange: TSX
CEO: Rostislav Raykov
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News



Gathering Data... Please wait

Profile

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.

Contact Information

Website: www.fennecpharma.com
Email: info@fennecpharma.com
Main Phone: +1 919 636-4530
Address: 68 TW Alexander Drive
Address 2: P.O Box 13628
State: NC
City / Town: Research Triangle Park
Country: USA
Postal Code: 27709

Issuer Information

Exchange: TSX
CEO: Rostislav Raykov
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 5.93 $ 0. (0.00%)
Last Price 5.93 Change $ 0. Change % 0.00 Tick N/A
Bid 5.51 Bid Size 100.00 Ask 7.10 Ask Size 200.00
Open N/A High N/A Low N/A Prev Close 5.93
Last Trade Volume 0 52 Wk Hi 10.70 52 Wk Low 4.35
Market Cap 118 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 19,895,830.00 EPS (TTM) -0.90 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 23.24 23.24 23.24 23.24
Low Target Price Estimate 21.82 21.82 21.82 21.82
Mean Target Price Estimate 22.53 22.53 22.53 22.53
Standard Deviation 1 1 1 1
Date of Most Recent Estimate 04/02/18 04/02/18 04/02/18 04/02/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1